Argus lowered shares of Procter & Gamble (NYSE:PG – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday, Marketbeat.com reports.
Several other equities analysts have also commented on PG. Piper Sandler upped their target price on Procter & Gamble from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Friday, April 24th. Barclays lifted their price target on Procter & Gamble from $146.00 to $152.00 and gave the company an “equal weight” rating in a report on Tuesday, July 21st. Royal Bank Of Canada cut their price objective on shares of Procter & Gamble from $172.00 to $167.00 and set an “outperform” rating on the stock in a report on Thursday, April 9th. Bank of America decreased their target price on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating on the stock in a research report on Friday, July 10th. Finally, Raymond James Financial dropped their price target on shares of Procter & Gamble from $175.00 to $170.00 and set an “outperform” rating for the company in a research report on Tuesday, April 14th. Thirteen research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $161.52.
Check Out Our Latest Analysis on PG
Procter & Gamble Stock Performance
Procter & Gamble (NYSE:PG – Get Free Report) last released its earnings results on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, topping the consensus estimate of $1.41 by $0.02. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The firm had revenue of $21.20 billion during the quarter, compared to analysts’ expectations of $21.38 billion. During the same period in the previous year, the company earned $1.48 EPS. Procter & Gamble’s revenue for the quarter was up 1.5% on a year-over-year basis. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, equities analysts expect that Procter & Gamble will post 6.99 EPS for the current year.
Procter & Gamble Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 17th. Shareholders of record on Friday, July 24th will be paid a dividend of $1.0885 per share. The ex-dividend date is Friday, July 24th. This represents a $4.35 annualized dividend and a yield of 3.0%. Procter & Gamble’s dividend payout ratio is presently 65.71%.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the company. Cibc World Market Inc. lifted its position in shares of Procter & Gamble by 40.6% in the fourth quarter. Cibc World Market Inc. now owns 511,833 shares of the company’s stock valued at $73,351,000 after buying an additional 147,701 shares during the last quarter. World Investment Advisors increased its holdings in shares of Procter & Gamble by 15.9% during the 4th quarter. World Investment Advisors now owns 105,915 shares of the company’s stock worth $15,179,000 after acquiring an additional 14,492 shares during the last quarter. Resources Management Corp CT ADV increased its holdings in shares of Procter & Gamble by 41.8% during the 4th quarter. Resources Management Corp CT ADV now owns 81,511 shares of the company’s stock worth $11,681,000 after acquiring an additional 24,010 shares during the last quarter. Indivisible Partners bought a new stake in Procter & Gamble in the 4th quarter valued at $2,120,000. Finally, Manning & Napier Advisors LLC lifted its holdings in Procter & Gamble by 3,791.9% during the 4th quarter. Manning & Napier Advisors LLC now owns 11,053 shares of the company’s stock valued at $1,592,000 after purchasing an additional 10,769 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.
Key Stories Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: PG’s $3.8 billion acquisition of Thorne would expand its presence in vitamins, supplements and wellness products, providing a potential avenue for longer-term growth beyond its traditional consumer-staples categories. Procter & Gamble making $3.8 billion acquisition of supplements company Thorne
- Positive Sentiment: PureCycle Technologies reported that its first commercial recycled-resin deliveries to PG have begun, with select Downy detergent caps now in production. The development supports PG’s sustainability efforts and could help secure recycled materials for packaging. PureCycle Technologies Reports Second Quarter 2026 Results
- Neutral Sentiment: PG continues to be highlighted as a defensive consumer-staples and dividend stock amid market volatility. However, elevated Treasury yields may make dividend-paying equities somewhat less attractive relative to bonds. 5 Solid Dividend Stocks to Buy in August
- Negative Sentiment: Argus downgraded PG from “buy” to “hold.” The change removes a positive analyst catalyst and likely reflects concerns about valuation, modest recent sales growth and limited near-term upside.
- Negative Sentiment: Discussion surrounding the Thorne acquisition has focused on product quality and safety concerns. Although these are not confirmed problems, such concerns could increase reputational and integration risks for PG as it enters the supplements market. Procter & Gamble Buys Supplement Brand Thorne — People Have Thoughts
Procter & Gamble Company Profile
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Further Reading
- Five stocks we like better than Procter & Gamble
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
